Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder

Sponsor
Heinrich-Heine University, Duesseldorf (Other)
Overall Status
Unknown status
CT.gov ID
NCT04448470
Collaborator
(none)
130
2
12.2
65
5.3

Study Details

Study Description

Brief Summary

It is not yet known whether an analysis of daytime sleepiness over the course of the day can predict the diagnosis or severity of sleep apnea. The goal of the study is to examine whether a psychometric determination of daytime sleepiness can adequately and practicably record daytime sleepiness in patients with mainly sleep apnea in comparison to other standardized methods.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire for recording daytime sleepiness over the course of the day
  • Other: Anamnesis and physicial examination
  • Other: Questionnaire for quantifying daytime sleepiness
  • Diagnostic Test: Pulmonary function test
  • Diagnostic Test: Polygraphy

Detailed Description

Detailed Description: Sleep-related respiratory disorders are a common disease in the general population. Untreated sleep apnea is associated with an increased risk of accidents, an increased risk of perioperative complications and various cardiovascular diseases such as arterial hypertension, coronary heart disease or stroke. Sleep apnea is often undetected. As part of the diagnosis of sleep apnea, screening is usually carried out to assess the probability of pre-testing before a sleep medical examination by means of anamnesis, examination and recording of risk factors and comorbidities. Questionnaires play a decisive role here. The Epworth Sleepiness Scale (ESS) or the STOP BANG questionnaires are often used for this purpose. ESS asks about the probability of falling asleep in different situations. With STOP BANG, the points daytime tiredness, snoring, breathing stops and various risk factors such as age, sex, neck circumference, high blood pressure and overweight are asked. The quality of the questionnaire used to assess the risk of sleep apnea is of crucial importance, as it is usually the basis for the decision whether or not to perform further sleep medical diagnostics. To date, there is no established, easy-to-use method for measuring daytime sleepiness during the day. However, it can be assumed that the degree of daytime sleepiness can predict the presence of sleep apnea. In a proof-of-concept study, the psychometric determination of daytime sleepiness in a time series on one day in patients with mainly sleep apnea will be measured.

The following questions should be answered:
  1. Does daytime sleepiness in patients with sleep apnea measured by a scale-based, psychometric time-series test show one or more characteristic patterns over the day?

  2. Is there a relation between the degree of the scale based psychometric time series test for daytime sleepiness and the severity of sleep apnea?

  3. Is the test quality of the scale based psychometric time series test for predicting sleep apnea better than the established Epworth Sleepiness Scale or STOP BANG questionnaires.

The quantification of daytime sleepiness can potentially be of crucial importance both for diagnostic procedures and for the assessment of the use of therapeutic measures.

Study Design

Study Type:
Observational
Anticipated Enrollment :
130 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison Between the Situational and the Time-of-day Recording of Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder
Actual Study Start Date :
Jun 24, 2020
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
patients with a clinical suspicion of sleep apnea (n=150)

patients with a clinical suspicion of sleep apnea

Other: Questionnaire for recording daytime sleepiness over the course of the day
Questionnaire for recording daytime sleepiness over the course of the day

Other: Anamnesis and physicial examination
Anamnesis and physical examination, e.g. medication, comorbidities, complaints

Other: Questionnaire for quantifying daytime sleepiness
the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire

Diagnostic Test: Pulmonary function test
The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.

Diagnostic Test: Polygraphy
Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.

healthy subjects (n=10)

healthy subjects

Other: Questionnaire for recording daytime sleepiness over the course of the day
Questionnaire for recording daytime sleepiness over the course of the day

Other: Anamnesis and physicial examination
Anamnesis and physical examination, e.g. medication, comorbidities, complaints

Other: Questionnaire for quantifying daytime sleepiness
the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire

Diagnostic Test: Pulmonary function test
The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.

Diagnostic Test: Polygraphy
Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.

Outcome Measures

Primary Outcome Measures

  1. Prediction of Sleep Apnea [at Baseline]

    the degree of daytime sleepiness can predict the presence of sleep apnea the degree of daytime sleepiness can predict the presence of sleep apnea

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion criteria for patients

  • Age 18-80 years

  • Written informed consent to participate in this study

  • Patients with a clinical suspicion of sleep apnea

Exclusion criteria for patients:
  • Age <18 years

  • Lack of consent to participate in the study

  • Lack of willingness and ability to participate in the study

  • Pregnancy and breast feeding period

Inclusion criteria for healthy subjects:
  • Age 18-45 years

  • no internal or psychiatric illness requiring therapy

  • not long-term drug therapy

  • no known sleep apnea.

  • Written consent to participate in this study

Exclusion criteria for healthy subjects:
  • Patients with sleep apnea

  • Age <18 years or ≥ 45 years

  • Lack of consent to participate in the study

  • Pregnancy and breast feeding period

  • Lack of willingness and ability to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heinrich-Heine-University Düsseldorf North Rhine-Westphalia Germany 40225
2 Lung and Allergy Centre Neuss North Rhine-Westphalia Germany 41462

Sponsors and Collaborators

  • Heinrich-Heine University, Duesseldorf

Investigators

  • Study Chair: Malte Kelm, Prof. Dr., University Hospital Düsseldorf

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Klinik für Kardiologie, Pneumologie und Angiologie, Principle Investigator Dr. Stefanie Keymel, Heinrich-Heine University, Duesseldorf
ClinicalTrials.gov Identifier:
NCT04448470
Other Study ID Numbers:
  • 19-002
First Posted:
Jun 25, 2020
Last Update Posted:
Jun 25, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Klinik für Kardiologie, Pneumologie und Angiologie, Principle Investigator Dr. Stefanie Keymel, Heinrich-Heine University, Duesseldorf
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 25, 2020